Risk Factors for and Clinical Relevance of Incident and Progression of Cerebral Small Vessel Disease Markers in an Asian Memory Clinic Population

被引:47
|
作者
Gyanwali, Bibek [1 ,2 ]
Shaik, Muhammad Amin [1 ,3 ]
Tan, Boon Yeow [4 ]
Venketasubramanian, Narayanaswamy [5 ]
Chen, Christopher [1 ,2 ]
Hilal, Saima [1 ,2 ,6 ,7 ]
机构
[1] Natl Univ Hlth Syst, Memory Aging & Cognit Ctr, Singapore, Singapore
[2] Natl Univ Singapore, Dept Pharmacol, Singapore, Singapore
[3] Nanyang Technol Univ, Ageing Res Inst Soc & Educ, Singapore, Singapore
[4] St Lukes Hosp, Singapore, Singapore
[5] Raffles Hosp, Raffles Neurosci Ctr, Singapore, Singapore
[6] Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands
[7] Erasmus Univ, Med Ctr, Dept Radiol & Nucl Med, Rotterdam, Netherlands
基金
英国医学研究理事会;
关键词
Cerebral small vessel disease; clinical dementia rating; cognitive impairment; magnetic resonance imaging; vascular risk factors; WHITE-MATTER HYPERINTENSITIES; ELDERLY-PEOPLE; FUNCTIONAL DECLINE; BRAIN INFARCTS; MICROBLEEDS; LEUKOARAIOSIS; AGE; RELIABILITY; PREVALENCE; LACUNES;
D O I
10.3233/JAD-180911
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Cerebral small vessel disease (SVD) is one of the major contributors to cognitive impairment and dementia. However, data on the incidence and progression of SVD in an Asian population are lacking. Objective: The present study aims to investigate the incidence, progression, associated risk factors, and clinical relevance of SVD in a memory clinic setting. Methods: A prospective case-control study, where 346 patients underwent repeated brain MRI with a mean interval of 24.5 months, accessing white matter hyperintensities (WMH), lacunes and cerebral microbleeds (CMBs). Severity of cognitive impairment was assessed using Clinical Dementia Rating scale and change in clinical diagnosis. Data on demographics, vascular risk factors, and clinical history were collected at baseline. Results: The prevalence of significant WMH (Fazekas >= 2) was 56.6% at baseline which progressed to 59.0% at follow-up. Overall prevalence of CMBs increased from 42.2% to 47.4% (9% new cases) and lacunes increased from 31.8% to 33.2% (2.1% new cases). Hypertension was associated with WMH progression (OR: 1.78, 95%CI: 1.01, 2.99) and increasing age was associated with incident CMBs (OR: 1.04, 95%CI: 1.01, 1.08). Moreover, the use of lipid-lowering medications decreased the incidence of lacunes (OR: 0.15, 95% CI: 0.04, 0.61). The major risk factor for incident SVD was baseline SVD lesion load. WMH progression was associated with increased severity of cognitive impairment (OR: 1.95, 95%CI: 1.16, 3.23). Conclusion: Vascular risk factors and baseline severity of SVD lesion load were associated with progression of SVD. Furthermore, WMH progression was linked with increased severity of cognitive impairment. Future studies should be aimed to slow cognitive deterioration by preventing SVD related brain damage by targeting vascular risk factors.
引用
收藏
页码:1209 / 1219
页数:11
相关论文
共 50 条
  • [1] Cerebral Small Vessel Disease Progression Increases Risk of Incident Parkinsonism
    Jacob, Mina A.
    Cai, Mengfei
    Bergkamp, Mayra
    Darweesh, Sirwan K. L.
    Gelissen, Liza M. Y.
    Marques, Jose
    Norris, David G.
    Duering, Marco
    Esselink, Rianne A. J.
    Tuladhar, Anil M.
    de Leeuw, Frank-Erik
    ANNALS OF NEUROLOGY, 2023, 93 (06) : 1130 - 1141
  • [2] Orthostatic hypotension and its association with cerebral small vessel disease in a memory clinic population
    Wiersinga, Julia H. I.
    Rhodius-Meester, Hanneke F. M.
    Wolters, Frank J.
    Trappenburg, Marijke C.
    Lemstra, Afina W.
    Barkhof, Frederik
    Peters, Mike J. L.
    van der Flier, Wiesje M.
    Mueller, Majon
    JOURNAL OF HYPERTENSION, 2023, 41 (11) : 1738 - 1744
  • [3] The triglyceride glucose index is associated with the cerebral small vessel disease in a memory clinic population
    Zhang, Jiayu
    Hu, Ming
    Jia, Yanqiu
    Zhao, Shicong
    Lv, Peiyuan
    Fan, Mingyue
    Shi, Yuanyuan
    Jin, Wei
    JOURNAL OF CLINICAL NEUROSCIENCE, 2022, 104 : 126 - 133
  • [4] Risk factors and progression of small vessel disease-related cerebral abnormalities
    Schmidt, R
    Fazekas, F
    Enzinger, C
    Ropele, S
    Kapeller, P
    Schmidt, H
    AGEING AND DEMENTIA CURRENT AND FUTURE CONCEPTS, 2002, : 47 - 52
  • [5] Risk factors and progression of small vessel disease-related cerebral abnormalities
    Schmidt, R
    Fazekas, F
    Enzinger, C
    Ropele, S
    Kapeller, P
    Schmidt, H
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 2002, (62): : 47 - 52
  • [6] Branch atheromatous disease versus small vessel disease: Risk factors, vessel pathology, and clinical progression
    Kwon, J
    Rha, JH
    Shim, Y
    Ha, CK
    NEUROLOGY, 2001, 56 (08) : A288 - A288
  • [7] Progression of MRI markers in cerebral small vessel disease: Sample size considerations for clinical trials
    Benjamin, Philip
    Zeestraten, Eva
    Lambert, Christian
    Ster, Irina Chis
    Williams, Owen A.
    Lawrence, Andrew J.
    Patel, Bhavini
    MacKinnon, Andrew D.
    Barrick, Thomas R.
    Markus, Hugh S.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2016, 36 (01): : 228 - 240
  • [8] Relationship of Perivascular Space Markers With Incident Dementia in Cerebral Small Vessel Disease
    Hong, Hui
    Tozer, Daniel J.
    Markus, Hugh S.
    STROKE, 2024, 55 (04) : 1032 - 1040
  • [9] Risk factors, clinical characteristics and MRI features of cerebral small vessel disease
    Lv, Cuilan
    Yuan, Jun
    Yao, Yuan
    Han, Bin
    Hu, Yida
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (11): : 22729 - 22738
  • [10] Cerebral small vessel disease: neuroimaging markers and clinical implication
    Chen, Xiaodong
    Wang, Jihui
    Shan, Yilong
    Cai, Wei
    Liu, Sanxin
    Hu, Mengyan
    Liao, Siyuan
    Huang, Xuehong
    Zhang, Bingjun
    Wang, Yuge
    Lu, Zhengqi
    JOURNAL OF NEUROLOGY, 2019, 266 (10) : 2347 - 2362